Are CYP1A2*1F and *1C associated with clozapine tolerability? A preliminary investigation

Psychiatry Research

Volumn 189, Issue 3, 2011, Pages 483-

  Bolla, Emilio ^a   Bortolaso, Paola ^a   Ferrari, Marco ^a   Poloni, Nicola ^a   Callegari, Camilla ^a   Marino, Franca ^a   Lecchini, Sergio ^a   Vender, Simone ^a   Cosentino, Marco ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOZAPINE; CYTOCHROME P450 1A2; DIAZEPAM; MESSENGER RNA; NEUROLEPTIC AGENT;

ADULT; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CONSTIPATION; DROWSINESS; DRUG CLEARANCE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG TRANSFORMATION; DRUG WITHDRAWAL; ENZYME ACTIVITY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HEREDITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LETTER; LOW DRUG DOSE; LYMPHOCYTE COUNT; MALE; MENTAL DISEASE; MUSCLE STIFFNESS; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECOMMENDED DRUG DOSE; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TACHYCARDIA; VISUAL DISORDER; CASE REPORT; EPIDEMIOLOGY; GENETICS;

ADULT; ANTIPSYCHOTIC AGENTS; CAUSALITY; CLOZAPINE; CYTOCHROME P-450 CYP1A2; HUMANS; MALE; MENTAL DISORDERS; YOUNG ADULT;

EID: 80053443818     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.03.011     Document Type: Letter

References (0)